Resolve Therapeutics enters license with University of Washington for autoimmune disease treatment
Links shared publicly online about this topic.
- 736total visits
Resolve Therapeutics enters license with University of Washington for autoimmune disease treatment
Resolve Therapeutics, LLC today announced that it has entered into an exclusive license with the University of Washington for certain biologic compounds and technology developed to treat autoimmune diseases including systemic lupus erythematosus (SLE).
View full resource at news-medical.net
Tags: Autoimmune Disease, Lupus, Systemic Lupus Erythematosus, Disease and Condition, disease
Most Recently Shared on November 11, 2010 at 6:38 am By:
Resolve Therapeutics enters license with University of Washington for autoimmune disease treatment: Resolve Ther... http://bit.ly/bCzIRc
Advertisement
